BlackRock’s Cryo-Cell International CCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4K Sell
6,696
-7,287
-52% -$25.9K ﹤0.01% 5351
2026
Q1
$49.6K Buy
13,983
+1,118
+9% +$3.72K ﹤0.01% 5135
2025
Q4
$44.3K Buy
12,865
+516
+4% +$2.14K ﹤0.01% 5079
2025
Q3
$57.3K Sell
12,349
-440
-3% -$2.09K ﹤0.01% 4957
2025
Q2
$66.4K Sell
12,789
-592
-4% -$3.12K ﹤0.01% 4931
2025
Q1
$85.2K Sell
13,381
-258
-2% -$1.87K ﹤0.01% 4807
2024
Q4
$101K Sell
13,639
-18
-0.1% -$136 ﹤0.01% 4787
2024
Q3
$87K Buy
13,657
+516
+4% +$3.56K ﹤0.01% 4696
2024
Q2
$100K Buy
13,141
+207
+2% +$1.71K ﹤0.01% 4704
2024
Q1
$96.5K Sell
12,934
-316
-2% -$1.78K ﹤0.01% 4737
2023
Q4
$76.2K Sell
13,250
-158
-1% -$818 ﹤0.01% 4882
2023
Q3
$70.5K Sell
13,408
-553
-4% -$3.24K ﹤0.01% 4930
2023
Q2
$84.9K Buy
13,961
+1,503
+12% +$7.27K ﹤0.01% 4969
2023
Q1
$37.6K Buy
12,458
+402
+3% +$1.55K ﹤0.01% 5168
2022
Q4
$51K Buy
12,056
+268
+2% +$1.28K ﹤0.01% 5223
2022
Q3
$71K Sell
11,788
-335
-3% -$2.06K ﹤0.01% 5278
2022
Q2
$71K Buy
+12,123
New +$77.6K ﹤0.01% 5333

Other funds holding CCEL

BlackRock's CCEL Position: Q2 2026 in Review

BlackRock reduced its Cryo-Cell International (CCEL) stake by 52% in Q2 2026, selling an estimated $25.9K and leaving 6,696 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5351.

BlackRock first reported a position in CCEL in Q2 2022 and has held it in 17 quarters since. The position peaked at $101K in Q4 2024. 12 funds tracked by Wall St. Rank hold CCEL as of Q2 2026.

  • BlackRock held 6,696 shares of Cryo-Cell International worth $21.4K as of Q2 2026.
  • BlackRock sold 7,287 Cryo-Cell International shares in Q2 2026, an estimated $25.9K.
  • Cryo-Cell International made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5351 holding.
  • BlackRock first reported a position in Cryo-Cell International in Q2 2022 and has held it in 17 quarters since.
  • BlackRock's Cryo-Cell International position peaked at $101K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Cryo-Cell International as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.